The present size of the world population is approximately 6.5 billion, and unless we take
measures to reduce the growth rate in the near future, it may reach 7-9 billion, as per the
predictions made (United Nations, Population Prospects: 1998 edition). The rate of
population growth comes down to 2% per year, indicating a decreasing trend, according
to the current status. However, the average number of births is very much greater than
deaths (i.e., 9-100 million more births than deaths ), especially contributed by birth rate
in developing countries (Potts, 1990; Bongaarts, 1992; and 1996), the reason being advances
in medicare and improved living standards. It is understood that fertility factor plays an
important role in population growth rather than mortality component. A direct necessity
arises out of such population phenomenon to arrest growth, for which several
contraceptives have to be tried. It is estimated that approximately 500 million couples
worldwide have no access to contraception (Diczfalusy, 1999).
In addition to improved availability and access to contraceptive services, the
development of novel methods of contraception, which are safer, easy and comfortable,
is required to solve global population problem to a greater extent.
One of the challenging approaches would be to provide a safe and reliable method of
birth control by a contraceptive vaccine which effectively prevents the fertilization process.
Some attempts are being made in this direction considering gamete-specific antigens.
Sperm antigens are the potential candidates of immunocontraceptive vaccine which
effectively causes prevention of fertilization between an egg and sperm.
This paper emphasizes the genetic diversity and identification of antibodies produced
in response to sperm antigens.
Antibody Diversity of Sperm Antigens
There are many antigens existing on the sperm surface, such as Fertilization Antigens
(FA-1, FA-2) that can recognize zonapellucida, Sperm Protein (SP), Cleavage Signal Antigen
(CS), PH -20, A36 Antigen, Mouse Sperm Antigens (MSA-63, MSA-11) NZ-1, NZ-2 and
many other known antigens, which elicit an immense diversity of antibodies with their
variable expression.
|